Clinical Trial Update: SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SB939 in recurrent or metastatic prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SB939 (SB-939)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED